NR1H4 and chronic kidney disease: Consistently, a recent study demonstrated that FXR activation suppresses TGFBR1/TAK1 signaling via miR-135a-5p to inhibit inflammation and osteogenic differentiation of SMCs, thereby attenuating vascular calcification in CKD rats.669